Published in Medical Device Law Weekly, March 4th, 2007
"Licensing these patent rights allows us to monetize an asset that is not an area of focus for the company," said Frank Thomas, president and chief executive officer. "While we have opted to out-license patent rights for both electrical and mechanical stimulation of the vagus nerve, we have retained our intellectual property rights associated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.